These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 10077001)
1. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001 [TBL] [Abstract][Full Text] [Related]
2. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening. Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094 [TBL] [Abstract][Full Text] [Related]
4. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Wilson VS; Bobseine K; Lambright CR; Gray LE Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A). Africander DJ; Storbeck KH; Hapgood JP J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265 [TBL] [Abstract][Full Text] [Related]
6. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation. Warriar N; Pagé N; Koutsilieris M; Govindan MV J Steroid Biochem Mol Biol; 1993 Dec; 46(6):699-711. PubMed ID: 8274404 [TBL] [Abstract][Full Text] [Related]
7. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Leonhardt SA; Altmann M; Edwards DP Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965 [TBL] [Abstract][Full Text] [Related]
8. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Song LN; Coghlan M; Gelmann EP Mol Endocrinol; 2004 Jan; 18(1):70-85. PubMed ID: 14593076 [TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens. Kuil CW; Mulder E Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526 [TBL] [Abstract][Full Text] [Related]
10. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695 [TBL] [Abstract][Full Text] [Related]
12. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690 [TBL] [Abstract][Full Text] [Related]
13. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Klokk TI; Kurys P; Elbi C; Nagaich AK; Hendarwanto A; Slagsvold T; Chang CY; Hager GL; Saatcioglu F Mol Cell Biol; 2007 Mar; 27(5):1823-43. PubMed ID: 17189428 [TBL] [Abstract][Full Text] [Related]
14. Anti-androgen effects of cypermethrin on the amino- and carboxyl-terminal interaction of the androgen receptor. Hu JX; Li YF; Pan C; Zhang JP; Wang HM; Li J; Xu LC Toxicology; 2012 Feb; 292(2-3):99-104. PubMed ID: 22172556 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. Kemppainen JA; Lane MV; Sar M; Wilson EM J Biol Chem; 1992 Jan; 267(2):968-74. PubMed ID: 1730684 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. Wong C; Kelce WR; Sar M; Wilson EM J Biol Chem; 1995 Aug; 270(34):19998-20003. PubMed ID: 7650017 [TBL] [Abstract][Full Text] [Related]
17. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276 [TBL] [Abstract][Full Text] [Related]
18. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Warriar N; Pagé N; Koutsilieris M; Govindan MV Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795 [TBL] [Abstract][Full Text] [Related]
20. Regulation of renal N-nitrosodimethylamine demethylase activity by androgens, progestin, glucocorticoid, and estrogen in BALB/c mice. Ahir S; Mohla S Cancer Res; 1989 Jul; 49(14):3737-41. PubMed ID: 2786744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]